// App-Quantinova.ai

P10.10 : Trends in Treatment Patterns and Survival in Advanced NSCLC Patients Treated at Frankfurt University Hospital in 2012–2018

Researchers

Presenter

  • A. Wolf

Principal Investigators

  • S. Shaid

  • A. Calleja

  • R. Carroll

Medical Centers

  • Department of Medicine, Hematology/oncology, Goethe University, Frankfurt Am Main/DE

  • Real World Solutions, Iqvia, Frankfurt/DE

  • Centre for Observational Research & Data Sciences, Bristol Myers Squibb, Uxbridge/GB

  • Medical Clinic I, Department of Respiratory Medicine, University Hospital Frankfurt, Frankfurt Am Main/DE

  • Medical Oncology, Bristol Myers Squibb Gmbh & Co. Kgaa, Munich/DE

  • Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Braine-L’Alleud/BE

  • Epi-Fit, Bordeaux/FR

  • Health Economics Outcomes Research, Bristol-Myers Squibb, Princeton, NJ, USA

  • Real World Solutions, Iqvia, London/GB

  • University Cancer Center, University Hospital Frankfurt, Frankfurt Am Main/DE

Locations

  • Germany

  • France

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved